House Committee Approves Drug “Track and Trace” Bill

The U.S. House Energy and Commerce Committee has approved a bill that would create “lot-level tracing requirements for manufacturers, wholesale distributors, pharmacies and repackagers” of drugs, according to an AHA News Now report.

Advertisement
By: Staff

The so-called “track and trace” legislation would also would require the FDA to issue regulations on unit-level traceability by 2027.

The Senate Education, Labor and Pensions Committee is scheduled to consider somewhat similar “track and trace” legislation next week.

How the University of South Florida’s EP cardiac clinic drove 67% patient growth + doubled cardiac monitoring revenue

Recommended Whitepaper

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.